What is it about?
It is a potential radiopharmaceutical for prostate cancer that may identify a group of patients which could evolve in an agressive profile.
Featured Image
Why is it important?
It is a tracer of an enzyme, that is overexpressed in prostate cancer. It is molecular target that has not been evaluated.
Perspectives
The characterization of this tracer in patients is being done.
Eduardo Savio
CUDIM
Read the Original
This page is a summary of: Biological and dosimetric evaluation of [11C]S-adenosyl Methionine as a potential agent for prostate cancer diagnosis, Cancer Research Frontiers, April 2018, Cancer Research Frontiers,
DOI: 10.17980/2018.27.
You can read the full text:
Contributors
The following have contributed to this page
